Latest Incentive Structures News

Buru Energy has launched a prospectus offering over 207 million new options free-attaching to a recent $5.3 million placement, aiming to back the commercialisation of its Rafael Gas Project and bolster working capital.

RLF AgTech has revamped its executive remuneration to tie CEO incentives directly to share price hurdles, revenue growth, and operating cash flow, reinforcing its focus on sustainable profitability.

Rokeby Resources appoints Richard Beazley as Managing Director and Tim Pallas as Chairman, signalling a strategic leadership overhaul to support the acquisition and development of the high-grade Omeo Gold Project in Victoria.

Argent Minerals appoints mining veteran Mike McKevitt as CEO to spearhead advancement of its flagship Kempfield Silver Project and evaluate growth across gold and copper assets.

Helia Group appoints Mark Senkevics as CEO from December 2026 and Craig Ward as CFO from July 2026, outlining detailed remuneration and transition plans amid ongoing leadership changes.

Raiz Invest announces a leadership change with Brendan Malone stepping down as CEO and Craig Keary taking over, signalling a new chapter for the fintech amid steady growth.

Harvest Technology Group has appointed Veronica Bainton as CEO, signalling a sharpened focus on defence markets and scaling its Nodestream platform internationally.

Australian Clinical Labs appoints Greg Horan as Group CEO effective August 2026, marking a leadership transition after a decade under Melinda McGrath. Horan’s healthcare and operational expertise positions ACL for its next growth phase.

IPH Limited has appointed Tony O’Malley as its new CEO starting July 2026, bringing over 30 years of global legal and professional services experience, including AI-driven transformation expertise.

Prophecy International has appointed Jonathan Drake as CEO effective July 2026, aiming to strengthen leadership after a period of interim management and strategic recalibration.

Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.

Geopacific Resources shakes up leadership with Hamish Bohannan as new Managing Director and Rowan Johnston as Chairman, aligning the company for Woodlark’s transition from DFS to development.